Literature DB >> 7946000

The problems with high dose pancreatic enzyme preparations.

C J Taylor1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7946000     DOI： 10.2165/00002018-199411020-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  22 in total

1.  Cystic fibrosis of the pancreas with varying degrees of pancreatic insufficiency.

Authors:  R R DOOLEY; F GUILMETTE; H LEUBNER; P R PATTERSON; H SHWACHMAN; C WEIL
Journal:  AMA J Dis Child       Date:  1956-10

2.  Human postprandial gastric emptying of 1-3-millimeter spheres.

Authors:  J H Meyer; J Elashoff; V Porter-Fink; J Dressman; G L Amidon
Journal:  Gastroenterology       Date:  1988-06       Impact factor: 22.682

3.  Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine.

Authors:  R Gow; R Bradbear; P Francis; R Shepherd
Journal:  Lancet       Date:  1981-11-14       Impact factor: 79.321

4.  High-strength pancreatic enzymes.

Authors:  J A Innes; A P Greening; K Webb
Journal:  Lancet       Date:  1994-03-05       Impact factor: 79.321

5.  High-strength pancreatic enzymes.

Authors:  C E Milla; C L Wielinski; W J Warwick
Journal:  Lancet       Date:  1994-03-05       Impact factor: 79.321

6.  A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis.

Authors:  I M Bowler; S P Wolfe; H M Owens; T A Sheldon; J M Littlewood; M P Walters
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

7.  Recurrent acute pancreatitis in patients with cystic fibrosis with normal pancreatic enzymes.

Authors:  H Shwachman; E Lebenthal; K T Khaw
Journal:  Pediatrics       Date:  1975-01       Impact factor: 7.124

8.  cAMP-regulated whole cell chloride currents in pancreatic duct cells.

Authors:  M A Gray; S Plant; B E Argent
Journal:  Am J Physiol       Date:  1993-03

9.  Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis.

Authors:  N N Huang; D V Schidlow; T H Szatrowski; J Palmer; L R Laraya-Cuasay; W Yeung; K Hardy; L Quitell; S Fiel
Journal:  Am J Med       Date:  1987-05       Impact factor: 4.965

10.  Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.

Authors:  R L Smyth; D van Velzen; A R Smyth; D A Lloyd; D P Heaf
Journal:  Lancet       Date:  1994-01-08       Impact factor: 79.321
View more
  1 in total

Review 1.  Adverse drug events related to dosage forms and delivery systems.

Authors:  I F Uchegbu; A T Florence
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.